Insomnia in Patients with Depression: Some Pathophysiological and Treatment Considerations

ISSN： 1172-7047

Source： CNS Drugs, Vol.23, Iss.4, 2009-01, pp. : 309-329

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Treatment of Patients with Insomnia and Excessive Daytime Sleepiness: Pharmacokinetic Considerations

By Nishino S. Mignot E.

Clinical Pharmacokinetics, Vol. 37, Iss. 4, 1999-10 ,pp. : 305-330

Adis International

Access to resources Recommend Favorite

Treatment of Anxiety and Depression in Transplant Patients: Pharmacokinetic Considerations

By Crone C.C.

Clinical Pharmacokinetics, Vol. 43, Iss. 6, 2004-01 ,pp. : 361-394

Adis International

Access to resources Recommend Favorite

Depression in Patients with Schizophrenia: Prevalence, and Diagnostic and Treatment Considerations

By Hausmann A.

CNS Drugs, Vol. 14, Iss. 4, 2000-10 ,pp. : 289-299

Adis International

Access to resources Recommend Favorite

Drug Treatment of Depression in HIV-Positive Patients: Safety Considerations

By Pieper Andrew A.

Drug Safety, Vol. 28, Iss. 9, 2005-01 ,pp. : 753-762

Adis International

Access to resources Recommend Favorite

Safety Considerations in Drug Treatment of Depression in HIV-Positive Patients: An Updated Review

By Watkins Crystal C.

Drug Safety, Vol. 34, Iss. 8, 2011-08 ,pp. : 623-639

Adis International

Access to resources Recommend Favorite